antibioticsАнтибиотики и ХимиотерапияAntibiot Khimioter = Antibiotics and Chemotherapy0235-2990ООО «Издательство ОКИ»antibiotics-253Research ArticleОБЗОРЫREVIEWSИнтерфероны первого типа — индукция и механизмы противовирусного действияType 1 Interferons: Induction and Mechanisms of Antiviral ActionВасильевА. Н.VasilyevA. N.noemail@neicon.ruМалиновскаяВ. В.MalinovskayaV. V.noemail@neicon.ruПарфеновВ. В.ParfenovV. V.noemail@neicon.ruДмитриеваЕ. В.DmitrievaE. V.noemail@neicon.ruИнститут доклинической и клинической экспертизы лекарственных средств ФГУ НЦЭСМП, МоскваРоссияInstitute of Preclinical and Clinical Investigation of Drugs, MoscowRussian FederationНаучно-исследовательский институт эпидемиологии и микробиологии имени почетного академика Н. Ф. Гамалеи РАМН, МоскваРоссияN. F. Gamaleya Research Institute of Epidemiology and Microbiology, Russian Academy of Medical Sciences, MoscowRussian Federation200913052020547-85055Copyright © Васильев А.Н., Малиновская В.В., Парфенов В.В., Дмитриева Е.В., 20202020Васильев А.Н., Малиновская В.В., Парфенов В.В., Дмитриева Е.В.Vasilyev A.N., Malinovskaya V.V., Parfenov V.V., Dmitrieva E.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.antibiotics-chemotherapy.ru/jour/article/view/253ReferencesIsaacs A., Lindenmann J. Virus interference. I. The interferon. Proc R. Soc Lond B Biol Sci 1957; 147: 258—267Isaacs A., Lindenmann J. Virus interference. I. The interferon. Proc R. Soc Lond B Biol Sci 1957; 147: 258—267Cantell K., Hirvonen S., Kauppinen H. L., Myllyla G. Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods Enzymol. 1981; 78: 29—38Cantell K., Hirvonen S., Kauppinen H. L., Myllyla G. Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods Enzymol. 1981; 78: 29—38Friesen H. J., Stein S., Evinger M. et al. Purification and molecular characterization of human fibroblast interferon. Arch Biochem Biophys 1981; 206: 432—450Friesen H. J., Stein S., Evinger M. et al. Purification and molecular characterization of human fibroblast interferon. Arch Biochem Biophys 1981; 206: 432—450Rubinstein M., Rubinstein S., Familetty P. C. et al. Human leukocyte interferon purified to homogeneity. Science 1978; 202: 1289—1290.Rubinstein M., Rubinstein S., Familetty P. C. et al. Human leukocyte interferon purified to homogeneity. Science 1978; 202: 1289—1290.Stein S., Kenny C., Fnesen H. J. et al. NH2-Terminal amino acid sequence of human fibroblast interferon. Proc Natl Acad Sci USA 1980; 77: 5716—5719.Stein S., Kenny C., Fnesen H. J. et al. NH2-Terminal amino acid sequence of human fibroblast interferon. Proc Natl Acad Sci USA 1980; 77: 5716—5719.Maeda S., McCandliss R., Gross M. et al. Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon. Ibid; 7010—7013.Maeda S., McCandliss R., Gross M. et al. Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon. Ibid; 7010—7013.Nagata S., Taira H., Hall A. et al. Synthesis in E.coli of a polypeptide with human leukocyte interferon activity. Nature 1980; 284: 316—320.Nagata S., Taira H., Hall A. et al. Synthesis in E.coli of a polypeptide with human leukocyte interferon activity. Nature 1980; 284: 316—320.Goeddel D. V., Yelverton E., Ullrich A. et al. Human leukocyte interferon produced by E.coli is biologically active. Ibid; 287; 411—416.Goeddel D. V., Yelverton E., Ullrich A. et al. Human leukocyte interferon produced by E.coli is biologically active. Ibid; 287; 411—416.Derynck R., Content J., DeClercq E. Isolation and structure of human fibroblast interferon gene. Ibid; 285: 542—547.Derynck R., Content J., DeClercq E. Isolation and structure of human fibroblast interferon gene. Ibid; 285: 542—547.Houghton M., Stewart A. G., Doel S. M. et al. The amino-terminal sequence of human fibroblast interferon as deduced from reverse transcripts obtained using synthetic oligonucleotide primers. Nucleic Acids Res 1980; 8: 1913—1931.Houghton M., Stewart A. G., Doel S. M. et al. The amino-terminal sequence of human fibroblast interferon as deduced from reverse transcripts obtained using synthetic oligonucleotide primers. Nucleic Acids Res 1980; 8: 1913—1931.Taniguchi T., Ohno S., Fujii-Kuriyama Y. et al. The nucleotide sequence of human fibroblast interferon cDNA. Gene; 1980: 10: 11—15.Taniguchi T., Ohno S., Fujii-Kuriyama Y. et al. The nucleotide sequence of human fibroblast interferon cDNA. Gene; 1980: 10: 11—15.Biron C. A., Sen G. C. Interferons and other cytokines, p. 321—351 // In D. M. Knipe, P. M. Howley, D. E. Griffin, M. Martin, B. Roizman and S. E. Straus (ed.) Fields virology. 2001. 4th ed. Lippincott-Raven; Philadelphia, Pa.Biron C. A., Sen G. C. Interferons and other cytokines, p. 321—351 // In D. M. Knipe, P. M. Howley, D. E. Griffin, M. Martin, B. Roizman and S. E. Straus (ed.) Fields virology. 2001. 4th ed. Lippincott-Raven; Philadelphia, Pa.Pestka S. The Interferons: 50 years after their discovery, there is much more to learn. Journ of Biol Chem 2007; 282: 28: 20047—20051.Pestka S. The Interferons: 50 years after their discovery, there is much more to learn. Journ of Biol Chem 2007; 282: 28: 20047—20051.Foster G. R., Germain C., JonesM. et al. Human T cells elicit IFN-alpha secretion from dendritic cells following cell to cell interactions. Eur J Immunol 2000; 30: 3228—3235.Foster G. R., Germain C., JonesM. et al. Human T cells elicit IFN-alpha secretion from dendritic cells following cell to cell interactions. Eur J Immunol 2000; 30: 3228—3235.Bach E. A., Agreet M., Schreiber R. D. The IFN gamma receptor: a paradigm for cytokine receptor signalling. Annu Rev Immunol 1997; 15: 563—591.Bach E. A., Agreet M., Schreiber R. D. The IFN gamma receptor: a paradigm for cytokine receptor signalling. Annu Rev Immunol 1997; 15: 563—591.Malmgaard L. Induction and regulation of IFNs during viral infection. J Interferon and Cytokine Res 2004; 24: 8: 439—454.Malmgaard L. Induction and regulation of IFNs during viral infection. J Interferon and Cytokine Res 2004; 24: 8: 439—454.Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783—801.Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783—801.Matsumoto M., Funami K., Tanabe M. et al. Subcellular localization of toll-like receptor 3 in human dendritic cells. J Immunol 2003; 171: 3154—3162.Matsumoto M., Funami K., Tanabe M. et al. Subcellular localization of toll-like receptor 3 in human dendritic cells. J Immunol 2003; 171: 3154—3162.Choe J., Kelker M. S., Wilson I. A. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 2005; 309: 581—585.Choe J., Kelker M. S., Wilson I. A. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 2005; 309: 581—585.Yamamoto M., Sato S., Hemmi H. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signalling pathway. Science 2003; 301; 640—643.Yamamoto M., Sato S., Hemmi H. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signalling pathway. Science 2003; 301; 640—643.Hoebe K., Du X., Georgel P. et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003; 424; 743—748.Hoebe K., Du X., Georgel P. et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003; 424; 743—748.Hemmi H., Takeuchi O., Sato S. et al. The roles of two IkappaB kinase-related kinases in lipopolysaccharides and double stranded RNA signalling and viral infection. J Exp Med 2004; 199: 1641—1650.Hemmi H., Takeuchi O., Sato S. et al. The roles of two IkappaB kinase-related kinases in lipopolysaccharides and double stranded RNA signalling and viral infection. J Exp Med 2004; 199: 1641—1650.Perry A. K., Chow E. K., Goodnough J. B. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med 2004; 199: 1651—1658.Perry A. K., Chow E. K., Goodnough J. B. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med 2004; 199: 1651—1658.Uematsu S., Akira S. Toll-like receptors and type I interferons. J of Biol Chem 2006; 282: 21: 15319—15323.Uematsu S., Akira S. Toll-like receptors and type I interferons. J of Biol Chem 2006; 282: 21: 15319—15323.Takeda K., Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1—14.Takeda K., Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1—14.Honda K., Taniguchi T. IRFs: master regulators of signalling by toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006; 6: 644—658.Honda K., Taniguchi T. IRFs: master regulators of signalling by toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006; 6: 644—658.Kurt-Jones E. A., Popova L., Kwinn L. et al. Pattern-recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000; 1: 398—401.Kurt-Jones E. A., Popova L., Kwinn L. et al. Pattern-recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000; 1: 398—401.Rassa J. C., Meyers J. L., Zhang Y. et al. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci USA 2002; 99: 2281—2286.Rassa J. C., Meyers J. L., Zhang Y. et al. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci USA 2002; 99: 2281—2286.McGettrick A. F., Brint E. K., Palsson-McDermott E. M. et al. Trif-related adapter molecule is phosphorylated by PKCe during toll-like receptor 4 signalling. Ibid 2006; 103: 9196—9201.McGettrick A. F., Brint E. K., Palsson-McDermott E. M. et al. Trif-related adapter molecule is phosphorylated by PKCe during toll-like receptor 4 signalling. Ibid 2006; 103: 9196—9201.Compton T., Kurt-Jones E.A., Boehme K. W. et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2. J of Virol 2003; 77: 8: 4588—4596.Compton T., Kurt-Jones E.A., Boehme K. W. et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2. J of Virol 2003; 77: 8: 4588—4596.Kurt-Jones E. A., Chan M., Zhou S. et al. Herpes simplex virus 1 interaction with toll-like receptor 2 contributes to lethal encephalitis. PNAS 2004; 101: 5: 1315—1320.Kurt-Jones E. A., Chan M., Zhou S. et al. Herpes simplex virus 1 interaction with toll-like receptor 2 contributes to lethal encephalitis. PNAS 2004; 101: 5: 1315—1320.Meylan E., Tschopp J. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Molecular Cell 2006; 22: 561—569.Meylan E., Tschopp J. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Molecular Cell 2006; 22: 561—569.Pestka S., Langer J. A. , Zoon K. C., Samuel C. E. Interferons and their actions. Ann Rev Biochem 1987; 56: 317—332.Pestka S., Langer J. A. , Zoon K. C., Samuel C. E. Interferons and their actions. Ann Rev Biochem 1987; 56: 317—332.Samuel C. E. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 1991; 183: 1—11.Samuel C. E. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 1991; 183: 1—11.Stark G. R., Kerr J.M., Williams B. R. et al. How cells respond to interferons. Ann Rev Biochem 1998; 67: 227—264.Stark G. R., Kerr J.M., Williams B. R. et al. How cells respond to interferons. Ann Rev Biochem 1998; 67: 227—264.Knipe D. M., Samuel C. E., Palese P. Virus-host cell interactions, p. 133—170 // In D. M. Knipe, P. M. Howley, D. E. Griffin, M. Martin, B. Roizman and S. E. Straus (ed.) Fields virology, 2001. 4th ed. Lippincott-Raven; Philadelphia, Pa.Knipe D. M., Samuel C. E., Palese P. Virus-host cell interactions, p. 133—170 // In D. M. Knipe, P. M. Howley, D. E. Griffin, M. Martin, B. Roizman and S. E. Straus (ed.) Fields virology, 2001. 4th ed. Lippincott-Raven; Philadelphia, Pa.Samuel C. E. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14: 4: 778—809.Samuel C. E. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14: 4: 778—809.Mogensen K. E., Lewerenz M., Reboul J. et al. The type I interferon receptor: structure, function and evolution of a family business. J Interferon Cytokine Res 1999; 19: 1069—1098.Mogensen K. E., Lewerenz M., Reboul J. et al. The type I interferon receptor: structure, function and evolution of a family business. J Interferon Cytokine Res 1999; 19: 1069—1098.Deweerd N. A., Shamith A., Samarajiwa, P. J. Hertzog. Type I interferon receptors: biochemistry and biological functions. J Biol Chem 2007; 282: 28: 20053—20057.Deweerd N. A., Shamith A., Samarajiwa, P. J. Hertzog. Type I interferon receptors: biochemistry and biological functions. J Biol Chem 2007; 282: 28: 20053—20057.Heim M. H. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus. J Receptor Signal Transduction Res 1999; 9: 75—120.Heim M. H. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus. J Receptor Signal Transduction Res 1999; 9: 75—120.Shindler C., Levy D. E., Decker T. JAK-STAT signalling: from interferons to cytokines. J Biol Chem 2007; 282: 28: 20059—20063.Shindler C., Levy D. E., Decker T. JAK-STAT signalling: from interferons to cytokines. J Biol Chem 2007; 282: 28: 20059—20063.Ozato K., Tailor P., Kubota T. The interferons regulatory factor family in host defense: mechanism of action. Ibid; 20065—20069.Ozato K., Tailor P., Kubota T. The interferons regulatory factor family in host defense: mechanism of action. Ibid; 20065—20069.Platanias L. C. Mechanisms of type-I and type-II-interferon-mediated signalling. Nat Rev Immunol 2005; 5: 375—386.Platanias L. C. Mechanisms of type-I and type-II-interferon-mediated signalling. Nat Rev Immunol 2005; 5: 375—386.Gil M. P., Bohn E., O'Guin A. K. et al. Biologic consequences of STAT-1-independent IFN-signalling. Proc Natl Acad Sci USA 2001; 98: 6680—6685.Gil M. P., Bohn E., O'Guin A. K. et al. Biologic consequences of STAT-1-independent IFN-signalling. Proc Natl Acad Sci USA 2001; 98: 6680—6685.Gil J., Alcami J., Esteban M. Induction of apoptosis by double-stranded RNA-dependent protein kinase PKR involves the a subunit of eucariotic translation initiation factor 2 and NF-kB. Mol Cell Biol 19: 4653—4663.Gil J., Alcami J., Esteban M. Induction of apoptosis by double-stranded RNA-dependent protein kinase PKR involves the a subunit of eucariotic translation initiation factor 2 and NF-kB. Mol Cell Biol 19: 4653—4663.Barber G. N. Host defence, viruses and apoptosis. Cell Death Differ 2001; 8: 2: 113—126.Barber G. N. Host defence, viruses and apoptosis. Cell Death Differ 2001; 8: 2: 113—126.Le Bon A., Schiavoni G., D'Agostino G. et al. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001; 14: 461—70.Le Bon A., Schiavoni G., D'Agostino G. et al. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001; 14: 461—70.Biron C. A. Role of early cytokines, including a and β interferons (IFN a/β), in innate and adaptive immune responses to viral infections. Semin Immunol 1998; 5: 383—390.Biron C. A. Role of early cytokines, including a and β interferons (IFN a/β), in innate and adaptive immune responses to viral infections. Semin Immunol 1998; 5: 383—390.Pien G. C., Nguyen B., Malmgaard L. et al. A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J Immunol 2002; 169: 5827—5837.Pien G. C., Nguyen B., Malmgaard L. et al. A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J Immunol 2002; 169: 5827—5837.Garcia-Sastre A., Biron C. A. Type 1 intreferons and the virus-host relationship: a lesson in detente. Science 2006; 312: 879—882.Garcia-Sastre A., Biron C. A. Type 1 intreferons and the virus-host relationship: a lesson in detente. Science 2006; 312: 879—882.
The authors declare that there are no conflicts of interest present.